Emerging Cancer Diagnostic Tests and Companies Developing New Technologies and Products
NEW YORK, Sept. 13, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Emerging Cancer Diagnostic Tests and Companies Developing New Technologies and Products
http://www.reportlinker.com/p0365346/Emerging-Cancer-Diagnostic-Tests-and-Companies-Developing-New-Technologies-and-Products.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
The report provides a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects, for the major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.
The report presents an overview of the clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as extensive listings of companies, universities and research centers developing or marketing new technologies, products, and applications.
Contains 260 pages and 30 tables
Table of Contents
Major Current And Emerging Cancer Diagnostic Tests
1. Introduction
2. Tumor Marker Classification
3. ACTH
4. Alpha-Fetoprotein (AFP)
5. Beta-2 Microglobulin
6. CA 15-3/27.29
7. CA 19-9
8. CA-125
9. Calcitonin
10. Carcinoembrionic Antigen (CEA)
11. Estrogen and Progesterone Receptors
12. Ferritin
13. Gastrin
14. Human Chorionic Gonadotropin (HCG)
15. Insulin
16. Lymphocytes CD4/CD8
17. NSE
18. Occult Blood
19. PAP Smear/HPV
20. Prostatic Acid Phosphatase (PAP)
21. Prostate-Specific Antigen (PSA)
22. Squamous Cell Carcinoma Antigen (SCC)
23. TdT
24. Thyroglobulin
25. Tissue Polypeptide Antigen (TPA)
26. Biochemical Tumor Markers
ADA
B-Protein
PNP
5'-Nucleotidase
27. Oncogenes
Abl/abl-bcr
AIB1
APC
BTA 26
BCL-2
BCR-ABL
B-raf
BRCA
CD44
CDK
C-abl
C-fos
C-myb
C-myc
CYCD1
CYP-17
DPC
E-myc
Erb-B
HER-2/neu
HPC1
HSTF
L-myc
MET
MSH
NEU
N-myc
N-telopeptide
PCA3
PIK3CA
PTI-1
P10
P40
P51
P53
Ras
Reg
RET
sFas
Sis
Src
28. Polypeptide Growth Factors
Basic Fibroblast Growth Factor
Beta-TGF
Cachectin (TNT)
Calmodulin
ECFR
Nerve Growth Factor (NGF)
Epidermal Growth Factor (EGF)
Ornithine Decarboxylase
Transferrin
Transforming Growth Factor-Alpha
29. Ectopic Hormones
30. Colony Stimulating Factors
31. Lymphokines
Alpha-Interferon
B Cell Growth Factors
B Cell Growth Factor (BCGF)
Gamma-Interferon
Interleukin-1 (IL-1)
Macrophage Activating Factor
32. Immunohistochemical Stains
33. Emerging Tumor Markers
N-Acetylglucosamine
Actin
Alpha-Actin
Angiogenin
Angiostatin
Antineuronal Antibodies
7B2
B72.3
B-Protein
Bax
BCD-F9
BLCA-4
Blood Group Antigens A,B,H
BTA
CA 50
CA 72-4/TAG-72
CA 195
CA-242
CA-549
Cadherin
CAM 26
CAR-3
CD105
Cathepsin-D
Chromogranin A and B
Cluster 1 Antigen
Cluster-5/5A Antigen
COX Antigen
CTA
CU18
Cyclin
DR-70
DU-PAN-2
Endometrial Bleeding Associated Factor
Endostatin
Epithelial Membrane Antigen
FDP
Feulgen Hydrolysis
Fibronectin
FSH
(1->3)-L-fucosyltransferase
Gastrin-Releasing Peptide (GRP)
GDCFP-15
Glucagon
Glycoamines
H23
HAAH
hk3
HPA
HSP27
Human Carcinoma Antigen
ICAM
Intermediate Filaments
Cytokeratins/CK18/Cyfra 21-1
Desmin
Gliofibrillary Acid Protein
Neurofilaments
Vimentin
KA 93
Kallikrein
Kinases
KP16D3
LAI
Leukocyte Common Antigen
Lewis Antigens
Lysophosphatidic Acid (LPA)
Ma 695/Ma 552
MABDF3
MAG
ME1
Minactivin
MN/CA9
MSA
Mucin Cancer Antigen (MCA)
Multiple Tumor Suppressor 1
Myosin
NEA-130
NMP22
Nucleolar
OA-519
Opiod Peptides
P-glycoprotein
Pancreatic Oncofetal Antigen (POA)
Parathyrcoid Hormone
Placental Lactogen
PR92
Proliferative Index, Ki-67
Px
RB Inactivation/Deletion
Ret
S-100 Protein
SCCL 175
Selectin
Serotonin
Sialic Acid
Sialyl SSEA-1/SLX
SN10
Somatostatin
TA-90
TABA
Tachykinin
TAG 12
TPS
Troponin
Tubulin
VCAM
VEGF
Villen
White Blood Cell Markers
To order this report:
In Vitro Diagnostic Industry: Emerging Cancer Diagnostic Tests and Companies Developing New Technologies and Products
In Vitro Diagnostic Business News
Check our Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article